openPR Logo
Press release

Narcolepsy Therapeutics Market Set to Reach USD 7.7 Billion by 2033, Driven by Greater Awareness and Advanced Treatments

05-14-2025 10:02 AM CET | Health & Medicine

Press release from: Emergen Research

Narcolepsy Therapeutics Market

Narcolepsy Therapeutics Market

The global Narcolepsy Therapeutics Market is projected to grow from USD 3.7 billion in 2024 to USD 7.7 billion by 2033, registering a compound annual growth rate (CAGR) of 8.50%, according to recent industry analysis.

This growth is being largely driven by rising awareness and improved diagnosis of narcolepsy worldwide. Organizations such as the National Institutes of Health (NIH), along with both government and nonprofit health bodies, have been working to improve public understanding of narcolepsy-a chronic sleep disorder that affects about 1 in 2,000 people globally.

The Narcolepsy Therapeutics market research report is broadly bifurcated in terms of product type, application spectrum, end-user landscape, and competitive backdrop, which would help readers gain more impactful insights into the different aspects of the market. Under the competitive outlook, the report's authors have analyzed the financial standing of the leading companies operating across this industry. The gross profits, revenue shares, sales volume, manufacturing costs, and the individual growth rates of these companies have also been ascertained in this section. Our team has accurately predicted the future market scope of the new entrants and established competitors using several analytical tools, such as Porter's Five Forces Analysis, SWOT analysis, and investment assessment.

Request a Sample Report with Table of Contents and Figures to click Here: @ https://www.emergenresearch.com/request-sample/4586

Despite its symptoms such as excessive daytime sleepiness and sudden muscle weakness (cataplexy), narcolepsy often remains undiagnosed due to limited public and clinical awareness. However, ongoing educational campaigns and medical research have significantly improved diagnostic rates in recent years. Advances in diagnostic tools like polysomnography (PSG) and multiple sleep latency tests (MSLT) have also helped doctors identify the condition more efficiently.

Groups such as the Narcolepsy Network in the U.S. and the European Narcolepsy Network have played a key role in raising awareness and supporting patients. This shift has helped recast narcolepsy from being seen merely as a sleep disorder to being recognized as a serious medical condition, increasing the number of patients actively seeking treatment.

Another major growth factor in the market is the development of new and effective treatment options. Approved drugs like sodium oxybate (Xyrem) and pitolisant (Wakix) have improved the way narcolepsy is managed, especially for those suffering from symptoms like cataplexy and chronic fatigue. These treatments have gone through rigorous testing and approval processes, ensuring their effectiveness and safety.

In addition to medications, non-drug therapies like cognitive behavioral therapy for insomnia (CBT-I) are being used alongside pharmaceutical treatments to help patients better manage their condition. Researchers are also exploring next-generation treatment options, including gene therapy and immune-based therapies, which could further improve outcomes in the future.

However, despite these advances, the high cost of narcolepsy treatments remains a significant barrier for many. Sodium oxybate, one of the most commonly prescribed drugs, can cost thousands of dollars per month, placing a heavy financial burden on patients-particularly those in lower-income regions or without strong health insurance coverage. While government programs and healthcare reforms are working to address these cost issues, affordability continues to be a major concern that could hinder wider market growth.

When looking at market segmentation by disease type, narcolepsy with cataplexy (Type 1) holds the largest share. This type accounts for over half of all narcolepsy cases and is typically treated with medications such as sodium oxybate, which helps manage both sleepiness and muscle weakness. Due to its higher prevalence and greater treatment needs, Type 1 dominates the market.

Meanwhile, the fastest-growing segment is narcolepsy without cataplexy (Type 2). Though less common, this form is now being diagnosed more frequently thanks to improved diagnostic tools and growing public awareness. As more targeted drugs become available for Type 2 patients, this segment is experiencing rapid growth.

Competitive Landscape

The report presents a holistic investigation of the Narcolepsy Therapeutics business mechanism and growth-oriented approaches undertaken by the leading companies operating in this market. The report highlights the numerous strategic initiatives, such as new business deals and collaborations, mergers & acquisitions, joint ventures, product launches, and technological upgradation, implemented by the leading market contenders to set a firm foot in the market. Hence, this section is inclusive of the company profiles of the key players, total revenue accumulation, product sales, profit margins, product pricing, sales & distribution channels, and industry analysis.

Leading Players Profiled in the Report Include:

Avadel Pharmaceuticals

Axsome Therapeutics Inc.

Harmony Biosciences

Jazz Pharmaceuticals PLC

Mylan N.V.

Novartis AG

Rhodes Pharmaceuticals L.P.

Shionogi Inc.

Takeda Pharmaceutical Company

Teva Pharmaceuticals Industries Ltd

XWPharma Ltd.

Requesting A Customised Report @https://www.emergenresearch.com/request-for-customization/4586

Narcolepsy Therapeutics Market Segmentation Analysis

Disease Type Outlook (Revenue, USD Billion; 2020-2033)

Narcolepsy with cataplexy (type 1)

Narcolepsy without cataplexy (type 2)

Secondary narcolepsy

Treatment Type Outlook (Revenue, USD Billion; 2020-2033)

Central nervous system stimulants

Sodium oxybate

Selective serotonin reuptake inhibitor

Tricyclic antidepressants

Histamine H3 receptor antagonists

Distribution Channel Outlook (Revenue, USD Billion; 2020-2033)

Retail pharmacies

Hospital pharmacies

Other pharmacies

The global Narcolepsy Therapeutics market is classified into the following regions:

North America (the U.S., Canada)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Europe (the U.K., Italy, Germany, France, Rest of EU)

Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

The Middle East & Africa (Saudi Arabia, the U.A.E., South Africa, Rest of MEA)

To Read More About The Report, Visit @https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market

Key Points Covered in This Section:

Regional contribution

Estimated revenue generation

Vital data and information about the consumption rate in all the leading regional segments

An expected rise in market share

Forecast growth in the overall consumption rate

Report Highlights:

Besides offering a vivid depiction of the global Narcolepsy Therapeutics business sphere and its fundamental operations, the latest report provides the industrial chain analysis and list down the current and future market trends and growth opportunities.

The report includes information on the present and historical market scenarios, which helps forecast the market conditions over the next eight years (2020-2027).

The report scrutinizes the salient factors influencing the growth of the market in the near future.

The strategic marketing recommendations, crucial information related to the new market entrants, and expansion plans of various businesses are poised to provide the reader with a competitive edge in the market.

To Purchase Now, Click Here @https://www.emergenresearch.com/select-license/4586

We appreciate you reading our report. Please contact us if you need the most recent report customised in any way. Our team will work with you to ensure that the report is created in accordance with your needs.

Read More Related Report

Narcolepsy Therapeutics Market Size @ https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market/market-size

Narcolepsy Therapeutics Market Share @ https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market/market-share

Narcolepsy Therapeutics Market Trends @ https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market/market-trends

Narcolepsy Therapeutics Regional Market Demand @ https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market/regional-market-demand

Narcolepsy Therapeutics Market Analysis @ https://www.emergenresearch.com/industry-report/narcolepsy-therapeutics-market/market-analysis

Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Narcolepsy Therapeutics Market Set to Reach USD 7.7 Billion by 2033, Driven by Greater Awareness and Advanced Treatments here

News-ID: 4015125 • Views:

More Releases from Emergen Research

Bioinformatics Market Poised for Strong Growth Driven by Personalized Medicine and Genomic Advancements
Bioinformatics Market Poised for Strong Growth Driven by Personalized Medicine a …
The global bioinformatics market size was USD 10.80 Billion in 2022 and is expected to register a revenue CAGR of 13.4% during the forecast period. The global bioinformatics market is set for significant expansion, driven by its growing role in personalized medicine, agricultural biotechnology, and genomics research. Bioinformatics, which uses computer-based tools to analyze biological data, is becoming indispensable in drug discovery, disease diagnosis, and genetic research. Key software like
Global Collagen Market Booms as Demand Rises Across Food, Beauty, and Healthcare Industries
Global Collagen Market Booms as Demand Rises Across Food, Beauty, and Healthcare …
The global collagen market size was USD 4,559.2 Million in 2023 and is expected to register a rapid revenue CAGR of 5.2% during the forecast period. The global collagen market is experiencing rapid growth, driven by increasing demand in food and beverage, healthcare, and personal care industries. Consumers are becoming more aware of collagen's health benefits, such as improving skin elasticity, joint health, and overall wellness, leading to a surge
Facial Recognition Market Sees Growth Driven by Rising Demand Across Airports, Smartphones, and Retail
Facial Recognition Market Sees Growth Driven by Rising Demand Across Airports, S …
The Facial Recognition Market is expected to grow from an estimated USD 6.9 billion in 2024 to USD 28.3 billion in 2033, at a CAGR of 17.00%. The global facial recognition market is experiencing significant growth, driven by increasing adoption across a wide range of industries including airports, smartphones, retail, and healthcare. This expansion is supported by the growing need for secure, contactless identity verification and enhanced surveillance capabilities. One of
Global Avionics Market Poised for Strong Growth Driven by Rising Aircraft Demand and Technological Advancements
Global Avionics Market Poised for Strong Growth Driven by Rising Aircraft Demand …
The global avionics market size reached USD 44.50 Billion in 2021 and is expected to register a revenue CAGR of 8.2% during the forecast period. The global avionics market is witnessing significant growth, fueled by increasing demand for military aircraft from emerging economies, growing aircraft deliveries, and the rising need for advanced flight systems. Emerging nations are expanding their defense capabilities, which has led to a surge in military aircraft

All 5 Releases


More Releases for Narcolepsy

Narcolepsy Drugs Market Trends and Dynamic 2028
Global Narcolepsy Drugs Market: Overview The narcolepsy drug pipeline has been dotted with medications that can target several symptoms of neurological sleep disorder. These symptoms are characterized notably under narcolepsy type 1 and narcolepsy type 2. An array of psychostimulants have gained favor among clinicians as third-line therapy. The global narcolepsy market has made strides driven by advances adjunctive behavioral techniques. To know Untapped Opportunities in the Market https://www.tmrresearch.com/sample/sample?flag=B&rep_id=6068 Moreover, constant development of
A Comprehensive Study exploring Narcolepsy Therapeutics Market
A new research study from HTF MI with title Global Narcolepsy Therapeutics Market Size, Status and Forecast 2025 provides an in-depth assessment of the Narcolepsy Therapeutics including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies. The research study provides forecasts for Narcolepsy Therapeutics investments till 2025. Access Sample Copy @: https://www.htfmarketreport.com/sample-report/1181484-global-narcolepsy-therapeutics-market-4 If you are involved in the Narcolepsy Therapeutics industry or intend
Narcolepsy Market entry and market expansion strategies
MarketResearchReports.Biz adds “Global Narcolepsy Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Narcolepsy and the growth estimates for the forecasted period. GlobalData's clinical trial report, Narcolepsy Global Clinical Trials Review, H1, 2018" provides an overview of Narcolepsy clinical trials scenario. This report provides top line data relating to the clinical trials on Narcolepsy. Report includes an overview of
Narcolepsy Market Trends, outlook and Opportunity Analysis 2019
Narcolepsy is a chronic neurological disorder, which is characterized by brain’s inability to control the sleep-wake cycle of an individual. This disorder is not caused due to any mental illness, but is mainly caused due to genetic abnormalities occurring from environmental factors or biologic factors. Narcoleptic individuals exhibita typical characteristic symptom, i.e. excessive daytime sleepiness (EDS), where individuals experience disturbed night sleep and abnormal daytime sleep pattern. Narcolepsy disorder is
Narcolepsy Treatment Pipeline Review H2 2017
Pune, India, 26th October 2017: WiseGuyReports announced addition of new report, titled “Narcolepsy - Pipeline Review, H2 2017”. Summary Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinations and sleep paralysis. Narcolepsy treatment includes lifestyle change, medication and counseling. Report Highlights Pharmaceutical and Healthcare latest pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics
Narcolepsy Market Pipeline Review, H2 2017
"The Report Narcolepsy - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy - Pipeline Review, H2 2017, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape. Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime